Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.96−0.06 (-2.97%)
Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –
Compugen revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $72.76M, up 161.1% from the year before. Over ten years it grew 35.3% a year on average. The highest annual figure on record is $72.76M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.76M | +161.1% |
| FY2024 | Dec 31, 2024 | $27.86M | -16.7% |
| FY2023 | Dec 31, 2023 | $33.46M | +346.1% |
| FY2022 | Dec 31, 2022 | $7.50M | +25.0% |
| FY2021 | Dec 31, 2021 | $6.00M | +200.0% |
| FY2020 | Dec 31, 2020 | $2.00M | -88.8% |
| FY2018 | Dec 31, 2018 | $17.80M | +2400.0% |
| FY2016 | Dec 31, 2016 | $712.00K | -92.3% |
| FY2015 | Dec 31, 2015 | $9.28M | -25.0% |
| FY2014 | Dec 31, 2014 | $12.37M | +248.5% |
| FY2013 | Dec 31, 2013 | $3.55M | +1366.5% |
| FY2012 | Dec 31, 2012 | $242.00K | -78.3% |
| FY2010 | Dec 31, 2010 | $1.12M | +346.0% |
| FY2009 | Dec 31, 2009 | $250.00K | – |
See a number that looks wrong?